Carlos Caparros

Carlos has had a long and successful career in the pharmaceutical industry, with over 30 years of experience in Global Clinical Operations. Before joining Athenex, he was Chief Medical Officer – South Region for CIDAL, Regional Director for Clinical Operations Latin America and Far East for Schering-Plough Research Institute (S-P), and Sr. Director Clinical Operations Latin America for Merck Sharp and Dohme (MSD). Carlos’ contributions include executing a bioequivalence trial in Argentina and Australia, which led to the global registration of a new formulation of Temodal for glioblastoma; developing the Schering Plough Global Data Management Center in Argentina; and most recently, executing the Phase 3 trial of Athenex’s oral paclitaxel and encequidar in metastatic breast cancer in Latin America.

Carlos received his M.D. from the University of Buenos Aires, School of Medicine, Argentina, and has a degree in Marketing and Pharmaceutical Business from the Universidad Abierta Interamericana in Buenos Aires, Argentina.